<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917731/" ref="ordinalpos=1661&amp;ncbi_uid=2986524&amp;link_uid=PMC2917731" image-link="/pmc/articles/PMC2917731/figure/F1/" class="imagepopup">Fig. 1.  From: FIP1L1/PDGFR?-Associated Systemic Mastocytosis. </a></div><br /><div class="p4l_captionBody">Intracellular signaling of FIP1L1/PDGFRα+ (F/P) cells. FIP1L1/PDGFRα+ (F/P) primary mouse eosinophils express up-regulated IL-5Rα and FIP1L1/PDGFRα activates the JAK2/STAT5 pathway. The CCR3/ERK1/2 signaling pathway may be amplified by FIP1L1/PDGFRα expression [25]. Up-regulated expressions of α4 integrin and Siglec-F were observed in FIP1L1/PDGFRα+murine eosinophils [8]. FIP1L1/PDGFRα synergizes with SCF stimulation via c-kit to activate Akt signaling in mouse mast cells. Eosinophils and mast cells also express c-kit and IL-5Rα, respectively.</div></div>